NCT06233942 2026-03-18
Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other Anticancer Therapies in Patients With Advanced Solid Tumors
BeOne Medicines
Phase 1 Recruiting
BeOne Medicines
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
EMD Serono
Wigen Biomedicine Technology (Shanghai) Co., Ltd.
Shanghai Junshi Bioscience Co., Ltd.